ea0099p102 | Pituitary and Neuroendocrinology | ECE2024
Urbani Claudio
, Corleo Davide
, Venturi Caterina
, Marconcini Giulia
, Bogazzi Fausto
, Lupi Isabella
, Santini Ferruccio
, Manetti Luca
Background: Cushing Syndrome (CS) is associated with metabolic disturbances, including obesity. The 1 mg Dexamethasone Suppression Test (1mgDST) is widely used to assess cortisol regulation in suspected CS patients. However, its interpretation may require adjustments based on individual factors, such as body mass index (BMI), due to obesitys influence on cortisol metabolism. The literature offers differing cutoff values for obese patients. This study aimed to establish B...